These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4689929)

  • 1. "Who shall establish drug standards"?
    Macek TJ
    J Am Pharm Assoc; 1973 Mar; 13(3):122-3. PubMed ID: 4689929
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of drug standards.
    Heller WM
    Am J Hosp Pharm; 1982 Apr; 39(4):652-3. PubMed ID: 7081247
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug standards laboratory enters second decade.
    Reese KM
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug product equivalence--are specifications necessary?
    Bergen JV
    J Am Pharm Assoc; 1972 Jan; 12(1):21-5. PubMed ID: 5007259
    [No Abstract]   [Full Text] [Related]  

  • 5. Product dissolution methods: response.
    Tingstad JE
    J Pharm Sci; 1973 Jul; 62(7):VI. PubMed ID: 4714144
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug standards and the dental practitioner.
    Feldmann EG
    J Oral Ther Pharmacol; 1965 Nov; 2(3):224-8. PubMed ID: 5849261
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug product quality--views of the regulators. USP/NF: public standards for drug product quality.
    Grady LT
    J Am Pharm Assoc; 1976 Nov; 16(11):603-4. PubMed ID: 977885
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug standards--communication and revision.
    Barnstein CH
    J Parenter Drug Assoc; 1979; 33(5):237-8. PubMed ID: 259643
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 10. Public standards for drugs: reflections on their use by the professions and industry.
    Miller LC
    Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of USP-NF to NDA and ANDA "Standards".
    Belson JJ
    Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269
    [No Abstract]   [Full Text] [Related]  

  • 12. Who shall establish drug standards?
    Levi RS
    J Am Pharm Assoc; 1973 Jan; 13(1):34-5. PubMed ID: 4682577
    [No Abstract]   [Full Text] [Related]  

  • 13. [The new drug formulary (NDF) of the German drug codex].
    Reimann H
    Pharm Unserer Zeit; 2010 Jul; 39(4):274-9. PubMed ID: 20589798
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the compendia in controlling factors affecting bioavailability of drug products.
    Blake MI
    J Am Pharm Assoc; 1971 Nov; 11(11):603-11. PubMed ID: 5133104
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacy's "hawks" and "doves".
    Feldmann EG
    J Am Pharm Assoc; 1968 Jul; 8(7):393-4. PubMed ID: 5665320
    [No Abstract]   [Full Text] [Related]  

  • 16. Voluntary standards--the USP and the PDA.
    Schmitz AJ
    J Parenter Drug Assoc; 1980; 34(6):425-6. PubMed ID: 6906364
    [No Abstract]   [Full Text] [Related]  

  • 17. The United States Pharmacopeia. Its value to the professions.
    Heller WM
    JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287
    [No Abstract]   [Full Text] [Related]  

  • 18. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 19. USP standards.
    Banes D
    Am J Hosp Pharm; 1976 Dec; 33(12):1245. PubMed ID: 998641
    [No Abstract]   [Full Text] [Related]  

  • 20. Particulate matter standards for small-volume injections.
    Belson JJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1527-8. PubMed ID: 3728492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.